Objective Inflammation and repair responses may be involved in atherosclerosis in rheumatoid arthritis (RA), although ...
Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced (armored) ...
CAR T-cell therapy has the potential to revolutionise how we treat certain types of cancer by genetically engineering someone’s own immune cells to attack the disease – but it is also cumbersome and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback